Epidemics may spread fast and since we are constantly improving our transportation possibilities, virus and bacteria are taking advantage of that. For centuries, harbours have been critical junctions through which diseases moved and diffused, and this led to the construction of specific buildings to isolate those who were sick or suspected of being infected. Nowadays we also have airports and much more persons moving all around the world, increasing the potential spread of infectious agents.
The European Centre for Disease Prevention and Control (ECDC) has decided to hold a two-days conference in Riga (Latvia) with ministers and high level representatives from the Ministries of Health, Social Affairs and Finance of the European Union, European Economic Area and Eastern Partnership Countries as well as high representatives of the European Commission, members of the European Parliament, representatives of international institu
The debate over measles vaccine is underway in many countries and, in some cases, the discussion came to court. It happened, for instance, in Italy in 2012, when a judge recognized the right to compensation (required by Italian law) for the family of a child vaccinated in 2002 with the trivalent vaccine MPR (measles-mumps-rubella) who were later diagnosed with autism. During the debate, the consultant of the family presented the research of the English physician Andrew Wakefield.
Recognize and respect fear. This is one of the main lessons Ron Klain claims to have learned by his efforts against Ebola. Klain has recently served as the first White House Ebola Response Coordinator, also known as the Ebola Czar. From such a high position, he got a close and deep insight into the dramatic threat to global health represented by the West Africa outbreak.
According to the last news from FluNews Europe, the current wave of influenza is causing a higher level of mortality among elderly people compared to the four previous seasons. In fact, an excess of all-cause mortality among the elderly (aged ≥65 years), concomitant with increased influenza activity and the predominance of A(H3N2) viruses, has been observed in recent weeks in Belgium, France, Portugal, Spain, Switzerland and the United Kingdom (England, Scotland and Wales).
After three years of activity, TELL ME project has reached its conclusion and the conference held in Venice on last December 4-5 was the occasion to present the project’s main products.
The recent terror attack in Paris has raised the fear in Europe, but the threat regards many countries all over the world. While the French drama was on, in Nigeria more than 2,000 people were killed and in the following days children were loaded with bombs and used as living weapons in the crowd. It is then clear that terrorist groups currently menacing the world have no scruples in using any kind of weapons. In this scenario, even a biological attack is an option that cannot be excluded.
ASSET members have approved and released the first three deliverables accomplished by the project. The first one is the report of the kick-off meeting, whose aim was to create the basis for a smooth project development, to review the overall Project timetable and to fine tune the work of the Consortium.
USA are experiencing a peak in influenza activity, with the influenza A(H3N2) viruses being the most recurrent strain so far this season. A(H3N2) viruses are predominating also in Europe and in both cases they exhibit antigenic differences to the virus included in the 2014–2015 northern hemisphere influenza vaccine.
